COLITIS
Clinical trials for COLITIS explained in plain language.
Never miss a new study
Get alerted when new COLITIS trials appear
Sign up with your email to follow new studies for COLITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New study aims to tame Immunotherapy's gut side effects
Disease control OngoingThis study compares two medications, infliximab and vedolizumab, for treating colitis (colon inflammation) caused by immune checkpoint inhibitor cancer therapy. About 47 adults with genitourinary cancer, melanoma, or non-small cell lung cancer who develop moderate to severe diarr…
Matched conditions: COLITIS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
Gut bacteria therapy aims to tame immunotherapy side effect
Disease control TerminatedThis study tested whether a treatment made from healthy gut bacteria (called restorative microbiota therapy) is safe and possible for people with severe colon inflammation caused by cancer immunotherapy. It was designed for patients whose colitis did not improve with steroids. Th…
Matched conditions: COLITIS
Phase: PHASE2 • Sponsor: University of Minnesota • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New scanner uses light and sound to see inflammation without needles
Diagnosis TerminatedThis study tests a new imaging device called MSOT that uses light and sound to detect inflammation in the skin or gut. Researchers will check if it is safe and can spot inflammation in people with graft-versus-host disease, Crohn's disease, or colitis. About 100 adults will have …
Matched conditions: COLITIS
Phase: NA • Sponsor: University of Oklahoma • Aim: Diagnosis
Last updated May 20, 2026 11:54 UTC
-
Texting your doctor: a new way to manage IBD?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether people with inflammatory bowel disease (IBD) have better outcomes and feel more in control of their health when they can text their medical team and regularly report symptoms via text surveys. About 900 participants will be split into two groups: one g…
Matched conditions: COLITIS
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC